CorrlensCorrlens
Correlate

Correlation Analysis

Amgen Inc vs Micron Technology, Inc.

AMGN vs MU

+0.688

Strong positive

When one moves up, the other tends to follow.

AMGN logo

Amgen Inc

AMGN

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Market cap 184.7B

MU logo

Micron Technology, Inc.

MU

Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.

Market cap 426B · 53,000 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcareTechnology

Time Series

Relative Performance

Green: AMGNGray: MU36 of 1,254 points (sampled)

Who Moves First

MU leads AMGN by 6 days

MU tends to move before AMGN.

After testing 13 timing shifts, the strongest relationship was +0.693 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.325

10 periods · Return correlation when both series rose

Both Falling

+0.117

9 periods · Return correlation when both series fell

Diverging

-0.813

16 periods · Return correlation when series moved apart

R-Squared

47.4%

Share of variance in one series explained by the other.

Trend Agreement

54.0%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.658, 0.716]

Scatter

XY Regression

197.3200250300350378.722100200300400443Amgen IncMicron Technology, Inc.Data pointsFit (r = 0.688)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

AMGN logo

Amgen Inc

AMGN

Market cap 184.7B

Stock · 1,254 raw → 1,254 prepared

Series B

MU logo

Micron Technology, Inc.

MU

Market cap 426B · 53,000 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

38

Estimated crossover points between normalized spreads.

Slope

1.3515

Linear regression slope.

Intercept

-259.7471

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 9 hours ago · ID: stock-amgn-vs-stock-mu-daily